Noxipoint Therapy Versus Standard Physical Therapy Using Electrical Stimulation for Chronic Pain

Sponsor
Pain Cure Center, California (Industry)
Overall Status
Completed
CT.gov ID
NCT01578148
Collaborator
(none)
34
1
2
10.1
3.4

Study Details

Study Description

Brief Summary

The purpose of this study is to validate the efficacy of Noxipoint(TM) therapy on chronic pain, and compare it with standard physical therapy using electrical stimulation on patients with chronic pain.

Invented by Dr. Charlie Koo at Stanford University, Noxipoint Therapy is a specific procedure with precise location, duration and intensity of TENS stimulation within the general FDA guidelines. The therapy substantially relieves general muscular/tendon pain and persistently restores the muscle and tendon function. The surface locations of nociceptors at the free nerve ending (i.e., "Noxipoints") are focused on in the stimulation therapy. Multiple clinical uses of Noxipoint Therapy confirmed the consistent efficacy of such stimulation at Noxipoints. An observational study of Noxipoint therapy within the FDA-approved use of TENS demonstrated an encouraging 93% success rate in eliminating the chronic pain, such as frozen shoulder pain, within 2-3 sessions. It is an order-of-magnitude improvement over the non-specific application of TENS and any other modalities in pain treatment. A unique neuro-immuno-signaling pathway that implicates the activation of adult stem cells, such as satellite cells in muscles, is implicated based on such a high success rate.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Noxipoint Therapy
  • Procedure: Physical Therapy
N/A

Detailed Description

View http://paincurecenter.com/Clinical_Outcome.html for the observational study mentioned in the Brief Summary above. For more detailed cases, please view http://paincurecenter.com/uploads/Nocipoint_therapy_clinical_study_w_o_ID_2011-2012.pdf

Study Design

Study Type:
Interventional
Actual Enrollment :
34 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Noxipoint Therapy vs. Standard Physical Therapy Using Electrical Stimulation for Chronic Pain
Study Start Date :
Apr 1, 2012
Actual Primary Completion Date :
Feb 1, 2013
Actual Study Completion Date :
Feb 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Noxipoint Therapy

Procedure: Noxipoint Therapy
Patients will be treated with a TENS device, following Noxipoint Therapy guidelines: Find the cause of the pain via Noxipoint: For each injured muscle/tissue, it is discovered that there are always a pair of points at the skin surface locations of its nociceptors that are painful at light press (named "Noxipoints"). Stimulate the corresponding pair of Nocipoints following a narrowly defined combination of intensity/ frequency (inducing the C-fiber response) and duration (about 1.5-3 minutes) of TENS at the two targeted Noxipoints. Repeat (a) to (b) above for each identified injured muscle group until all pain areas are eliminated or when the session time is up. Instruct the subject not to use the newly recovered muscle/tissue too much an estimated rest period depending on his/her age.
Other Names:
  • Koo's Pain Cure Therapy
  • Active Comparator: Physical Therapy

    Procedure: Physical Therapy
    The 1.5-hour physical therapy in the control arm are provided both as standard of care and sham device comparison to Nocipoint Therapy, following these guidelines: TENS stimulation (45 minutes): • Electrodes will be placed around the patient-identified general pain area on the neck /shoulder for TENS. Rotate the electrode pads around the pain area and stimulate again. Other modalities of PT per the therapist's choice: Infrared treatment on the pain areas (about 15 minutes) Manual therapy to cervical and/or rotator cuff areas (about 15 minutes). Exercise and training: Neck exercises: Range of motion exercises to include foraminal opening for about 15 minutes, and/or Shoulder exercise: Range of motion exercises to include walking the arm on the wall, rotation of the upper arm for about 15 minutes Hot/cold pack to the pain area for about 15 minutes
    Other Names:
  • PT
  • Outcome Measures

    Primary Outcome Measures

    1. Brief Pain Inventory (BPI) Severity of the Pain at Its Worst [One year]

      BPI will be evaluated as the score change from the baseline. As a supplemental measure, the baseline of individual patients will also be normalized to 100%, with the change being a percentile of the baseline.

    Secondary Outcome Measures

    1. BPI Severity of the pain in the other three occasions [One year]

      Besides the Severity of the Pain at Its Worst, there are three other pain measures in BPI. This measure will be used as a supporting measure fo the Primary Measure.

    2. BPI Interference of Function [One year]

      This measure is used to indicate the impact of the subject's quality of life. However, the standard questions include the therapy's functional impact on walking, which is not likely to be influenced by neck/shoulder pains in any case and thus may not be relevant. Thus, a supplemental measure excluding the impact on walking will be provided as a supplemental observation.

    3. Range of motion [One year]

      This measure will be taken whenever possible.

    4. Shoulder Pain and Disability Index (SPADI) [One year]

      SPADI will be taken from shoulder pain patients whenever possible. This is optional.

    5. Neck Disability Index (NDI) [One year]

      NDI will be taken from neck pain patients whenever possible. This is optional.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 64 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 18-64 years old male or female

    • Having chronic pain (ICD-9: 338.21, 338.29) in the neck/upper back (ICD-9: 723.1), or the shoulder (ICD-9: 719.41)

    • Pain duration over 6 months, with at least one month of history of other therapy treatments (Physical therapy, steroid injection, acupuncture, analgesic medicine, and/or massage therapy)

    Exclusion Criteria:
    • Patients with BPI Severity at its Worst below 5

    • Traumatic injury from external impact force

    • Pain caused by traumatic bone fractures

    • History of traumatic cervical injury

    • History of osteoporosis

    • Pain related to systemic inflammatory conditions including polymyalgia rheumatic, systemic lupus erythematosis

    • Signs of psychosomatic illness

    • Severe rheumatoid arthritis undergoing active treatment including DMARD biologics

    • Steroid injection on pain site within 4 weeks

    • Language and/or cognitive inability to complete the assessment questionnaires

    • Previous TENS for pain relief

    • For safety reasons, patients wearing cardiac pace makers, implanted defibrillator, or pregnant women

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Pain Cure Center Palo Alto California United States 94306

    Sponsors and Collaborators

    • Pain Cure Center, California

    Investigators

    • Study Director: Charles C Koo, PhD, Pain Cure Center
    • Principal Investigator: Charles C Koo, PhD, Pain Cure Center
    • Principal Investigator: David Lewis, MD, Stanford University

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Pain Cure Center, California
    ClinicalTrials.gov Identifier:
    NCT01578148
    Other Study ID Numbers:
    • NT-01-2012
    First Posted:
    Apr 16, 2012
    Last Update Posted:
    Apr 24, 2013
    Last Verified:
    Apr 1, 2013
    Keywords provided by Pain Cure Center, California
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 24, 2013